Open Access

Cardiac arrest following a glucose 30% bolus: what happened?

  • Philippe Goutorbe1Email author,
  • Nadia Kenane1,
  • Julien Bordes1,
  • Christophe Jego2,
  • Ambroise Montcriol1 and
  • Eric Meaudre1
Critical Care200812:401

https://doi.org/10.1186/cc6216

Published: 16 January 2008

A 74-year-old man was admitted with postoperative peritonitis. On day 45, a double-lumen central venous catheter was positioned in the patient's right subclavian vein. The distal lumen was used only for parenteral nutrition (2,000 ml/day Kabiven® 1600; Fresenius Kabi Brezin, France). Glucose 5% (250 ml) with 6 g potassium was infused, over 24 hours, via the proximal lumen. Hypokalemia was noted (K+, 3.0 mEq/l). An additional infusion of potassium was initiated (34 mEq in 10 ml, at 17 mEq/hour) via the proximal lumen.

One hour later hypoglycemia was detected, and 20 ml of 30% glucose was given intravenously. At the end of the injection, ventricular fibrillation developed. Cardiopulmonary resuscitation successfully restored adequate circulation within 12 minutes. Blood analysis performed using an ABL 700 (Radiometer, Copenhagen, Denmark) 1 minute after beginning cardiac resuscitation showed serum potassium of 5.1 mmol/l, ionised calcium of 1.1 mmol/l, and serum sodium of 140 mmol/l. The empty ampoule was checked, and had contained the correct solution. The cardiac rhythm had been normal before the glucose bolus was given, but sinus arrest with junctional or idioventricular escape rhythm developed at the end of bolus administration, immediately followed by ventricular fibrillation (Figure 1). The patient was discharged 2 weeks later without any sequelae.
Figure 1

Traces of the monitoring storage during glucose injection. The upper trace is an electrocardiogram showing sinus arrest, idioventricular or junctional escape rhythm immediately followed by ventricular fibrillation. The lower trace is the blood pressure.

Electrocardiographic changes are not usually seen until serum potassium exceeds 6.0–6.5 mmol/l. Disappearance of the P wave is usually seen when serum potassium exceeds 8 mmol/l [1]. We were surprised, however, to find changes in the absence of any increase in serum potassium. There was neither hyponatremia nor hypocalcemia, both of which increase sensitivity to hyperkalemia [2, 3]. Even if serum potassium was normal, we think it possible there could have been local hyperkalemia, which led to sinus arrest and then to ventricular fibrillation. The mechanism of this hyperkalemia, we postulate, is that the high potassium concentration (1,074 mmol/l) in the deadspace of the tubing was flushed by the glucose, corresponding to a 11 mEq intravenous bolus of K+.

The present case highlights a dangerous aspect of using concentrated solutions for K+ therapy. Although an infusion rate of 17 mEq/hour is usually considered safe, in the particular situation here, with a central venous catheter in an intrathoracic position, flushing the catheter created a bolus injection. Theoretically, such a poorly mixed bolus can cause dangerous concentrations in the coronary arteries. When using potassium supplements, catheters with minimum dead-space are preferable, and bolus injections should be avoided.

Declarations

Authors’ Affiliations

(1)
HIA Ste Anne Daru
(2)
HIA Ste Anne Cardiology

References

  1. Bonvini RF, Hendiri T, Anwar A: Sinus arrest and moderate hyperkalemia. Ann Cardiol Angeiol (Paris) 2006, 55: 161-163. 10.1016/j.ancard.2005.10.001View ArticleGoogle Scholar
  2. Mehta NJ, Chhabra VK, Khan IA: Sinus arrest or sinoventricular conduction in mild hyperkalemia. J Emerg Med 2001, 20: 163-164. 10.1016/S0736-4679(00)00295-XView ArticlePubMedGoogle Scholar
  3. Johnston HL, Murphy R: Agreement between an arterial blood gas analyser and a venous blood analyser in the measurement of potassium in patients in cardiac arrest. Emerg Med J 2005, 22: 269-271. 10.1136/emj.2003.013599PubMed CentralView ArticlePubMedGoogle Scholar

Copyright

© BioMed Central Ltd 2008

Advertisement